A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas.
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2014
At a glance
- Drugs Sorafenib (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2009 Planned end date changed from 1 Mar 2007 to 1 Mar 2009 as reported by ClinicalTrials.gov.